Clinical Trials Browser

Phase 1/2 × INDUSTRY × Other solid neoplasm × Clear all

NCT04174716 2026-04-17

VASTUS

Phase 1/2 Completed

Other solid neoplasm

Solid Tumors

NCT07537881 2026-04-17

A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC288 in the Treatment of Solid Tumors

Phase 1/2 Not yet recruiting

Other solid neoplasm

Solid Tumors

NCT07205718 2026-04-16

A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced or Metastatic Solid Tumors

NCT07266428 2026-04-16

A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT04219254 2026-04-15

A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT05275478 2026-04-15

Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors

Phase 1/2 Terminated

CNSGastrointestinalOther solid neoplasmSarcomaThoracic

Glioblastoma, Mesothelioma, Sarcoma, Cholangiocarcinoma, Neurofibrosarcoma

NCT06741644 2026-04-15

A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT05023486 2026-04-14

NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor Malignancies

Phase 1/2 Active not recruiting

Other solid neoplasm

Advanced or Metastatic Solid Tumor Malignancies

NCT06470763 2026-04-14

EXPAND-1

Phase 1/2 Active not recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT06685068 2026-04-14

A Phase 1/2 Study of GEN1286 in Patients With Advanced Solid Tumors

Phase 1/2 Terminated

Other solid neoplasm

Advanced Solid Tumor

NCT06362369 2026-04-13

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

Phase 1/2 Recruiting

DermatologicGastrointestinalGenitourinaryOther solid neoplasmThoracic

Turcot syndrome, Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Kidney Neoplasms, Liver Neoplasms, Melanoma, Neoplasm Metastasis, Skin Neoplasms, Colorectal Neoplasms

NCT07326488 2026-04-13

A Study of MHB009C in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Malignant Solid Tumor

NCT07509684 2026-04-13

A Phase Ib/II Study Evaluating Injectable ALK-N001 in Patients With Advanced Solid Tumors

Phase 1/2 Not yet recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT04626635 2026-04-09

COMBINE-EGFR-1

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT06635785 2026-04-09

BiPAVE-001

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT06885281 2026-04-09

A Study of ZL-1310 in Participants With Selected Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors

NCT07192107 2026-04-09

A Study of MHB042C in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Malignant Solid Tumor

NCT07192120 2026-04-09

A Study of MHB048C in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

GenitourinaryOther solid neoplasm

mCRPC (Metastatic Castration-resistant Prostate Cancer)

NCT07514975 2026-04-09

First-In-Human Study of KHN922 for Injection

Phase 1/2 Not yet recruiting

Other solid neoplasm

Advanced Solid Tumors Cancer

NCT05083481 2026-04-08

A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors

Phase 1/2 Active not recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT05262530 2026-04-08

Safety and Preliminary Efficacy Trial of BNT142 in Patients With CLDN6-positive Solid Tumors

Phase 1/2 Terminated

Other solid neoplasm

Solid Tumor

NCT05579366 2026-04-07

RAINFOL-01

Phase 1/2 Recruiting

BreastGynecologicOther solid neoplasmThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Fallopian Tube Neoplasms, Mesothelioma, Ovarian Neoplasms, Uterine Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT06911827 2026-04-07

A Study of QLP2117 in Combination With QL2107 in Advanced Solid Tumor Patients

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT03917381 2026-04-06

GEN1046 Safety Trial in Patients With Malignant Solid Tumors

Phase 1/2 Active not recruiting

Other solid neoplasm

Solid Tumors

NCT05732831 2026-04-06

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

Phase 1/2 Recruiting

GastrointestinalOther solid neoplasmSarcomaThoracic

Mesothelioma, Sarcoma, Cholangiocarcinoma, Neurofibrosarcoma

NCT07510815 2026-04-06

DUAL-MESO-NK

Phase 1/2 Recruiting

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

NCT07512583 2026-04-06

Clinical Studies of TQB2930 Injection for the Treatment of Advanced Solid Tumors

Phase 1/2 Not yet recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT07446153 2026-04-03

A Clinical Study of HRS-8364 in the Treatment of Advanced Solid Tumor Subjects

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT03744468 2026-04-02

Study of Surzebiclimab (BGB-A425) and Alcestobart (LBL-007) in Combination With Tislelizumab in Advanced Solid Tumors

Phase 1/2 Completed

147 enrolled 74 charts

Other solid neoplasmThoracic

Locally Advanced or Metastatic Solid Tumors for Phase 1, Dose Escalation and Phase 2 Safety Lead-in

NCT04665206 2026-04-02

Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasmThoracic

Mesothelioma

NCT07508761 2026-04-02

IPG7236 Combined With Toripalimab in Participants With Advanced Solid Tumors

Phase 1/2 Not yet recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT05773820 2026-04-01

A Study Explore WJB001 Capsules in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT07192432 2026-04-01

SENTRY-HER2

Phase 1/2 Recruiting

Other solid neoplasm

HER2 Expressing Solid Tumors

NCT07455734 2026-04-01

Early-phase Trial to Assess the Safety and Preliminary Efficacy of BNT3214 in Adults With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumor Cancer

NCT06833008 2026-03-31

A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid Tumours

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT05982522 2026-03-27

IN10018 Combination Therapy in Previously-treated Solid Tumors

Phase 1/2 Withdrawn

Other solid neoplasm

Solid Tumor

NCT06554795 2026-03-27

First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT06953323 2026-03-27

A Phase I/II Study of WJB001 Combination Therapy on Safety and Efficacy for Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT07396584 2026-03-27

HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors, Adult

NCT07436728 2026-03-27

A Study of TAK-505 in Adults With Solid Tumors

Phase 1/2 Not yet recruiting

Other solid neoplasm

Malignant Solid Tumors

NCT07446855 2026-03-27

PARTHENON

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumours

NCT06166836 2026-03-25

a Study to Evaluate the Safety and Efficacy of D-1553 Combined With IN10018 in KRAS G12C Mutant Solid Tumors

Phase 1/2 Active not recruiting

Other solid neoplasm

Solid Tumor

NCT06873789 2026-03-25

A Study to Evaluate INCB177054 in Participants With Select Advanced or Metastatic Solid Tumors

Phase 1/2 Active not recruiting

Other solid neoplasm

Solid Tumors

NCT06977737 2026-03-25

ATTEST

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT07300943 2026-03-25

Study in Advanced Solid Tumor Patients

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT06781125 2026-03-24

One Trial of JCXH-211 Intratumoral Injection Combined With Anti-PD-1 Antibody in Patients With Malignant Solid Tumors

Phase 1/2 Not yet recruiting

Other solid neoplasm

Malignant Solid Tumors

NCT07160725 2026-03-24

A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumours

NCT05886920 2026-03-23

A Phase 1/2 Study of D3S-002 as Monotherapy or Combination Therapy in Adult Subjects With Advanced Solid Tumors With MAPK Pathway Mutations

Phase 1/2 Active not recruiting

Other solid neoplasm

Advanced Solid Tumors With MAPK Pathway Mutations

NCT06253130 2026-03-23

A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT07222969 2026-03-23

A Clinical Study to Evaluate the Safety of VIB305 in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumors